keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ezatiostat hydrochloride (TLK199 HCl) 是一种新型谷胱甘肽类似物,可刺激淋巴细胞生成和骨髓祖细胞增殖,可用于治疗血细胞减少症和研究骨髓增生异常综合症。它也是口服活性的选择性谷胱甘肽 S-转移酶 P1-1 抑制剂,通过抑制 GSTP1导致 JNK 激活。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
2 mg | ¥ 427 | 待询 | ||
5 mg | ¥ 611 | 待询 | ||
10 mg | ¥ 997 | 待询 | ||
25 mg | ¥ 1,787 | 待询 | ||
50 mg | ¥ 2,764 | 待询 | ||
100 mg | ¥ 4,698 | 待询 | ||
200 mg | ¥ 6,995 | 待询 | ||
500 mg | ¥ 11,192 | 待询 | ||
1 mL * 10 mM (in DMSO) | ¥ 997 | 待询 |
Ezatiostat hydrochloride 的其他形式现货产品:
产品描述 | Ezatiostat hydrochloride (TLK199 HCl) is an effective inhibitor of glutathione S-transferase. Ezatiostat hydrochloride is a novel glutathione analog and the potential treatment of cytopenias. In addition, Ezatiostat hydrochloride has been revealed to selectively bind to and thus inhibit GSTP1-1. |
体外活性 | Because GST P1-1 can bind to and inhibit JNK, Ezatiostat hydrochloride has also been exhibited to inhibit GST P1-1, activate JNK, and promote the growth and maturation of hematopoietic progenitors in preclinical models. Moreover, Ezatiostat hydrochloride has been reported to stimulate the proliferation of myeloid precursors. Ezatiostat hydrochloride has been elucidated to induce growth inhibition and cellular apoptosis in human leukemia cells (CC50: 6-17μM). Apart from these, Ezatiostat hydrochloride has shown the stimulation of multilineage differentiation in mature monocytes, granulocytes, and erythrocytes [1][2]. |
体内活性 | Administration of Ezatiostat stimulates both lymphocyte production and bone marrow progenitor proliferation only in glutathione S-transferase P1-1 (GSTP1+/+) and not in GSTP1-/- animals[2]. |
别名 | TLK199 HCl, Ezatiostat盐酸盐, TER199 |
分子量 | 566.11 |
分子式 | C27H36ClN3O6S |
CAS No. | 286942-97-0 |
keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 28.3mg/mL (50.00 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 1.7664 mL | 8.8322 mL | 17.6644 mL | 44.161 mL |
5 mM | 0.3533 mL | 1.7664 mL | 3.5329 mL | 8.8322 mL | |
10 mM | 0.1766 mL | 0.8832 mL | 1.7664 mL | 4.4161 mL | |
20 mM | 0.0883 mL | 0.4416 mL | 0.8832 mL | 2.2081 mL | |
50 mM | 0.0353 mL | 0.1766 mL | 0.3533 mL | 0.8832 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Ezatiostat hydrochloride 286942-97-0 Metabolism Glutathione Peroxidase Glutathione transferases MDS lymphocyte proliferation Ezatiostat GSTs JNK tripeptide TLK199 HCl ERK1 GSTP1 Ezatiostat盐酸盐 inhibit Gutathione S-transferase TER199 TLK-199 TLK 199 TER 199 Ezatiostat Hydrochloride Apoptosis Inhibitor c-Jun TLK199 TER-199 inhibitor